Search filters

List of works by Norbert Grzasko

1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens

scientific article published on 22 May 2012

A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization.

scientific article published on 3 March 2014

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

scientific article published on 18 February 2020

Acute T cell lymphoblastic leukemia in the recipient of a renal transplant from a donor with malignant lymphoma

scientific article published on 09 June 2008

Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.

scientific article published on 6 June 2012

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

scientific article published on 22 November 2018

Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective--a report by Polish Myeloma Study Group.

scientific article

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

scientific article

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

scientific article published on 20 November 2019

Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group.

scientific article

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

scientific article published on 05 November 2020

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

scientific article

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

scientific article published on 19 April 2020

Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma

scientific article published on 16 February 2021

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

scientific article

Expression and Clinical Significance of Neuropilin-1 in Patients With Multiple Myeloma

scientific article published on 01 October 2020

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

scientific article published on 15 July 2021

F-fluoro-ethyl-tyrosine (F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study

scientific article published in 2019

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

article

High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group.

scientific article

Identification of miRSNPs associated with the risk of multiple myeloma.

scientific article

Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1.

scientific article

Involvement of apoptosis and proinflammatory cytokines in the pathogenesis of anemia in multiple myeloma

scientific article published in January 2004

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies

scientific article published on 08 May 2019

Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma.

scientific article published in August 2005

Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures.

scientific article published on 8 March 2006

Optimizing the treatment of patients with multiple myeloma and renal impairment

scientific article published on 05 October 2014

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

scientific article

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma

scientific article published on 20 November 2018

Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma.

scientific article

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.

scientific article published on 7 January 2018

Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients

scientific article published on 02 July 2018

Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.

scientific article published in March 2006

Thalidomide can promote erythropoiesis by induction of STAT5 and repression of external pathway of apoptosis resulting in increased expression of GATA-1 transcription factor

scientific article published on 29 May 2015

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.

scientific article

The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a “real-world” study: Polish Myeloma Group experience

scientific article published on 12 July 2018

The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group.

scientific article published on 2 June 2010

Therapy-related peripheral neuropathy in multiple myeloma patients.

scientific article

[Evaluation of blood morphology in patients with refractory multiple myeloma treated with thalidomide]

scientific article published on 01 July 2001

[Hemostatic and fibrinolysis markers in the early phase of acute ischaemic stroke]

scientific article published on 01 November 2004

Paulina is supported by:

About Paulina

Help